Skip to main content
Top
Published in: Tumor Biology 9/2014

01-09-2014 | Research Article

Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis

Authors: Qiuying Li, Ming Liu

Published in: Tumor Biology | Issue 9/2014

Login to get access

Abstract

Glutathione S-transferase T1 (GSTT1) polymorphic variation has been implicated as a risk factor for various cancers. However, previous studies investigating the association between GSTT1 null genotype and laryngeal cancer risk in Asians reported conflicting outcomes. In the present study, the possible association of laryngeal cancer risk with GSTT1 null genotype was explored by a meta-analysis. Relevant studies were identified through a systemic search of PubMed and Chinese National Knowledge Infrastructure databases. Six studies with a total of 1,824 individuals were included in the meta-analysis. The pooled odds ratio (OR) with 95 % confidence interval (CI) was used to assess the association. Meta-analysis of all included studies showed that there was an obvious association between GSTT1 null genotype and laryngeal cancer risk in Asians (OR = 2.41, 95 % CI 1.27–4.57, P = 0.007, I 2 = 86 %). After adjusting for heterogeneity, there was still an obvious association between GSTT1 null genotype and laryngeal cancer risk in Asians (OR = 1.75, 95 % CI 1.36–2.24, P < 0.001, I 2 = 0 %). The findings from the meta-analysis suggest that GSTT1 null genotype is associated with laryngeal cancer risk in Asians.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
go back to reference Beitler JJ, Muller S, Grist WJ, Corey A, Klein AM, Johns MM, et al. Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. J Clin Oncol. 2010;28:2318–22.CrossRefPubMed Beitler JJ, Muller S, Grist WJ, Corey A, Klein AM, Johns MM, et al. Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. J Clin Oncol. 2010;28:2318–22.CrossRefPubMed
3.
go back to reference Wolf GT. Routine computed tomography scanning for tumor staging in advanced laryngeal cancer: implications for treatment selection. J Clin Oncol. 2010;28:2315–7.CrossRefPubMed Wolf GT. Routine computed tomography scanning for tumor staging in advanced laryngeal cancer: implications for treatment selection. J Clin Oncol. 2010;28:2315–7.CrossRefPubMed
4.
5.
go back to reference Manjarrez ME, Ocadiz R, Valle L, Pacheco C, Marroquin A, De la Torre C, et al. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res. 2006;12:6946–51.CrossRefPubMed Manjarrez ME, Ocadiz R, Valle L, Pacheco C, Marroquin A, De la Torre C, et al. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res. 2006;12:6946–51.CrossRefPubMed
6.
go back to reference Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, et al. Regulation of the cell cycle gene, btg2, by mir-21 in human laryngeal carcinoma. Cell Res. 2009;19:828–37.CrossRefPubMed Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, et al. Regulation of the cell cycle gene, btg2, by mir-21 in human laryngeal carcinoma. Cell Res. 2009;19:828–37.CrossRefPubMed
7.
go back to reference Ying XJ, Dong P, Shen B, Xu CZ, Xu HM, Zhao SW. Glutathione S-transferase m1 gene polymorphism and laryngeal cancer risk: a meta-analysis. PLoS One. 2012;7:e42826.PubMedCentralCrossRefPubMed Ying XJ, Dong P, Shen B, Xu CZ, Xu HM, Zhao SW. Glutathione S-transferase m1 gene polymorphism and laryngeal cancer risk: a meta-analysis. PLoS One. 2012;7:e42826.PubMedCentralCrossRefPubMed
8.
go back to reference Lacko M, Voogd AC, Roelofs HM, Te Morsche RH, Ophuis MB, Peters WH, et al. Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk. Head Neck. 2013;35:858–67.CrossRefPubMed Lacko M, Voogd AC, Roelofs HM, Te Morsche RH, Ophuis MB, Peters WH, et al. Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk. Head Neck. 2013;35:858–67.CrossRefPubMed
9.
10.
go back to reference Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal. 2004;6:289–300.CrossRefPubMed Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal. 2004;6:289–300.CrossRefPubMed
11.
go back to reference Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.CrossRefPubMed Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.CrossRefPubMed
12.
go back to reference Hong YJ, Lee JK, Lee GH, Hong SI. Influence of glutathione S-transferase M1 and T1 genotypes on larynx cancer risk among Korean smokers. Clin Chem Lab Med. 2000;38:917–9.CrossRefPubMed Hong YJ, Lee JK, Lee GH, Hong SI. Influence of glutathione S-transferase M1 and T1 genotypes on larynx cancer risk among Korean smokers. Clin Chem Lab Med. 2000;38:917–9.CrossRefPubMed
13.
go back to reference Li Q, Wang L, Chen Y, Du Y, Kong P, Li Y, et al. Polymorphisms of gstm1, gstt1 and susceptibility of laryngeal and hypopharyngeal carcinomas. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;23:1105–7. 1111.PubMed Li Q, Wang L, Chen Y, Du Y, Kong P, Li Y, et al. Polymorphisms of gstm1, gstt1 and susceptibility of laryngeal and hypopharyngeal carcinomas. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;23:1105–7. 1111.PubMed
14.
go back to reference Nosheen M, Ishrat M, Malik FA, Baig RM, Kayani MA. Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev. 2010;11:881–5.PubMed Nosheen M, Ishrat M, Malik FA, Baig RM, Kayani MA. Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev. 2010;11:881–5.PubMed
15.
go back to reference Ruwali M, Singh M, Pant MC, Parmar D. Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer. Xenobiotica. 2011;41:1122–30.CrossRefPubMed Ruwali M, Singh M, Pant MC, Parmar D. Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer. Xenobiotica. 2011;41:1122–30.CrossRefPubMed
16.
go back to reference Tian S, Zhang J, Xiao Q, Zhai J, Yan X, Huang M, et al. [The association between genetic polymorphisms of gstm1, gstt1, gstp1 and susceptibility to laryngeal carcinoma from the Han people in Guangdong zone]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;25:204–10.PubMed Tian S, Zhang J, Xiao Q, Zhai J, Yan X, Huang M, et al. [The association between genetic polymorphisms of gstm1, gstt1, gstp1 and susceptibility to laryngeal carcinoma from the Han people in Guangdong zone]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;25:204–10.PubMed
17.
go back to reference Masood N, Kayani MA. Protection against laryngeal and pharyngeal carcinoma: heterozygous vs. homozygous deletions of GSTM1 and GSTT1. Genet Mol Biol. 2013;36:1–6.PubMedCentralCrossRefPubMed Masood N, Kayani MA. Protection against laryngeal and pharyngeal carcinoma: heterozygous vs. homozygous deletions of GSTM1 and GSTT1. Genet Mol Biol. 2013;36:1–6.PubMedCentralCrossRefPubMed
19.
go back to reference Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
20.
22.
go back to reference Ying XJ, Dong P, Shen B, Wang J, Wang S, Wang G. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. J Cancer Res Clin Oncol. 2011;137:1661–7.CrossRefPubMed Ying XJ, Dong P, Shen B, Wang J, Wang S, Wang G. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. J Cancer Res Clin Oncol. 2011;137:1661–7.CrossRefPubMed
23.
go back to reference Dong G, Tian Y, Chen S, Xu X, Zheng J, Li T. Glutathione S-transferase T1 null genotype is associated with oral cancer susceptibility in Asian populations. Tumour Biol. 2013;34:1753–7.CrossRefPubMed Dong G, Tian Y, Chen S, Xu X, Zheng J, Li T. Glutathione S-transferase T1 null genotype is associated with oral cancer susceptibility in Asian populations. Tumour Biol. 2013;34:1753–7.CrossRefPubMed
24.
go back to reference Zhao Y, Luo Y, Huang B, Qin B, Zhang T, Zhang J, et al. Gstt1 null genotype contributes to increased risk of gastric cancer in Chinese population: evidence from a meta-analysis. Tumour Biol. 2013;34:1691–7.CrossRefPubMed Zhao Y, Luo Y, Huang B, Qin B, Zhang T, Zhang J, et al. Gstt1 null genotype contributes to increased risk of gastric cancer in Chinese population: evidence from a meta-analysis. Tumour Biol. 2013;34:1691–7.CrossRefPubMed
25.
go back to reference Ying XJ, Xu CZ, Xu HM, Sun ZF, Zhang J, Wang GL, et al. Lack of association between glutathione S-transferase T1 gene polymorphism and laryngeal cancer susceptibility: a meta-analysis based on 2,124 cases and 2,059 controls. Gene. 2012;494:11–6.CrossRefPubMed Ying XJ, Xu CZ, Xu HM, Sun ZF, Zhang J, Wang GL, et al. Lack of association between glutathione S-transferase T1 gene polymorphism and laryngeal cancer susceptibility: a meta-analysis based on 2,124 cases and 2,059 controls. Gene. 2012;494:11–6.CrossRefPubMed
Metadata
Title
Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis
Authors
Qiuying Li
Ming Liu
Publication date
01-09-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 9/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2121-8

Other articles of this Issue 9/2014

Tumor Biology 9/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine